Jeff M Michalski

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. pmc Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406
    Jeff Michalski
    Department of Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 83:e363-70. 2012
  2. pmc Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:361-8. 2010
  3. pmc Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study
    Jeff M Michalski
    Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:14-22. 2010
  4. pmc Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117
    Jeffrey D Bradley
    Department of Radiation Oncology, Washington University School of Medicine, Alvin J Siteman Comprehensive Cancer Center, 4921 Parkview Place, St Louis, MO, USA
    J Clin Oncol 28:2475-80. 2010
  5. doi request reprint Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy
    Jesse N Aronowitz
    Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA
    Am J Clin Oncol 33:164-7. 2010
  6. ncbi request reprint PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
  7. ncbi request reprint Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
  8. ncbi request reprint Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
    Jeff M Michalski
    Department of Radiation Oncology, Washington University, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 56:192-8. 2003
  9. ncbi request reprint Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an update
    Carlos A Perez
    Department of Radiation Oncology, Washington University Medical Center, St Louis, MO, USA
    Clin Prostate Cancer 1:97-104. 2002
  10. ncbi request reprint Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 58:735-42. 2004

Collaborators

Detail Information

Publications49

  1. pmc Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406
    Jeff Michalski
    Department of Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 83:e363-70. 2012
    ..Report of clinical cancer control outcomes on Radiation Therapy Oncology Group (RTOG) 9406, a three-dimensional conformal radiation therapy (3D-CRT) dose escalation trial for localized adenocarcinoma of the prostate...
  2. pmc Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:361-8. 2010
    ..To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer...
  3. pmc Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study
    Jeff M Michalski
    Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:14-22. 2010
    ..To update the incidence of late toxicity of RTOG 9406, a three-dimensional conformal radiation therapy (3DCRT) dose escalation trial for prostate cancer...
  4. pmc Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117
    Jeffrey D Bradley
    Department of Radiation Oncology, Washington University School of Medicine, Alvin J Siteman Comprehensive Cancer Center, 4921 Parkview Place, St Louis, MO, USA
    J Clin Oncol 28:2475-80. 2010
    ..The radiation dose was 74 Gy given in 37 fractions. Radiation therapy volumes included those of the gross tumor and involved nodes. The volume of lung at or exceeding 20 Gy (V20) was mandated to be <or= 30%...
  5. doi request reprint Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy
    Jesse N Aronowitz
    Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA
    Am J Clin Oncol 33:164-7. 2010
    ..To determine whether there is an optimal type of mathematical equation for predicting seed and activity requirements for permanent prostate brachytherapy...
  6. ncbi request reprint PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
    ....
  7. ncbi request reprint Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
    ..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
  8. ncbi request reprint Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
    Jeff M Michalski
    Department of Radiation Oncology, Washington University, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 56:192-8. 2003
    ..To evaluate the rates of low-grade late effects in patients treated for prostate cancer on Radiation Therapy Oncology Group (RTOG) 9406...
  9. ncbi request reprint Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an update
    Carlos A Perez
    Department of Radiation Oncology, Washington University Medical Center, St Louis, MO, USA
    Clin Prostate Cancer 1:97-104. 2002
    ..Follow-up at > or = 10 years is needed to confirm these observations...
  10. ncbi request reprint Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 58:735-42. 2004
    ..This is the first report of the toxicity outcomes using dose level IV (74 Gy) on Radiation Therapy Oncology Group (RTOG) study 9406 for Stage T1-T2 prostate adenocarcinoma...
  11. doi request reprint Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience
    Daniel A Hamstra
    Department of Radiation Oncology, The University of Michigan Medical Center, Ann Arbor, MI 40185, USA
    Int J Radiat Oncol Biol Phys 86:546-53. 2013
    ....
  12. pmc Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy
    Jeffrey R Olsen
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Radiother Oncol 104:199-204. 2012
    ..Dose effects of intrafraction motion during prone prostate radiotherapy are unknown. We compared prone and supine treatment using real-time tracking data to model dose coverage...
  13. ncbi request reprint Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 62:706-13. 2005
    ..This is the first report of toxicity outcomes at dose Level V (78 Gy) on Radiation Therapy Oncology Group 9406 for Stages T1-T2 adenocarcinoma of the prostate...
  14. doi request reprint Long-term outcome in children treated for craniopharyngioma with and without radiotherapy
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Neurosurg Pediatr 1:126-30. 2008
    ..The authors report the results of surgery alone or in combination with radiotherapy in the management of craniopharyngiomas in children...
  15. ncbi request reprint Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406
    Jeff M Michalski
    Washington University Medical School, St Louis, MO 63110, USA
    Semin Radiat Oncol 12:75-80. 2002
    ..Clinical trials should use quality-of-life measures to determine that trade-offs between severity and rates of toxicity are acceptable to patients...
  16. ncbi request reprint Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
    Mary Feng
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 68:1417-23. 2007
    ..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
  17. doi request reprint Glioblastoma in children: a single-institution experience
    Stephanie M Perkins
    Department of Radiation Oncology and Mallinkrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Int J Radiat Oncol Biol Phys 80:1117-21. 2011
    ..However, even with this multispecialty approach, overall survival remains poor. To assess outcome and evaluate treatment-related prognostic factors, we retrospectively reviewed the experience at our institution...
  18. ncbi request reprint Uncertainties in radiation therapy: target volume definition in prostate cancer
    Carlos A Perez
    Department of Radiation Oncology, Washington University Medical Center, St Louis, MO 63108, USA
    Rays 28:267-88. 2003
    ..Multiple imaging methods are available and significant advances have been made in image fusion to enhance target volume definition. An exhaustive review of the literature is presented...
  19. pmc Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy
    Mingyao Zhu
    Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 85:1038-44. 2013
    ....
  20. ncbi request reprint Positron tomographic assessment of androgen receptors in prostatic carcinoma
    Farrokh Dehdashti
    The Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, 63110, USA
    Eur J Nucl Med Mol Imaging 32:344-50. 2005
    ....
  21. ncbi request reprint Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)
    Janice K Ryu
    Department of Radiation Oncology, University of California at Davis, 4501 X Street, Suite G126, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 54:1036-46. 2002
    ..This is a preliminary report of toxicity at Level III (79.2 Gy) on 3D Oncology Group/Radiation Therapy Oncology Group (RTOG) 9406...
  22. pmc A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117
    Jeffrey D Bradley
    Washington University School of Medicine, St Louis, Missouri, USA
    Int J Radiat Oncol Biol Phys 77:367-72. 2010
    ....
  23. pmc Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
    Hiram A Gay
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110 6311, USA
    Int J Radiat Oncol Biol Phys 83:e353-62. 2012
    ..To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials...
  24. ncbi request reprint Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:915-28. 2003
    ..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
  25. ncbi request reprint Long term outcome with post-operative radiation therapy for spinal canal ependymoma
    Sasha H Wahab
    Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
    J Neurooncol 83:85-9. 2007
    ..A retrospective study was performed to evaluate the long term efficacy and safety of post-operative radiation therapy in the management of spinal canal ependymoma at our institution...
  26. ncbi request reprint The efficacy of radiation therapy in the management of grade I astrocytomas
    Elizabeth A Kidd
    Department of Radiation Oncology and Mallinckrodt Institute of Radiology, St Louis, MO, USA
    J Neurooncol 76:55-8. 2006
    ....
  27. pmc Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking
    Jeffrey R Olsen
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA
    Int J Radiat Oncol Biol Phys 82:1903-11. 2012
    ..We present an analysis of PTV adequacy and a proposed adaptive process...
  28. doi request reprint Inter-institutional variation of implant activity for permanent prostate brachytherapy
    Jesse N Aronowitz
    Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Brachytherapy 7:297-300. 2008
    ..Despite the existence of guidelines for permanent prostate brachytherapy, it is unclear whether there is interinstitutional consensus concerning the parameters of an ideal implant...
  29. pmc Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03
    Christina Tsien
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
    Int J Radiat Oncol Biol Phys 73:699-708. 2009
    ..To evaluate in a Phase I trial the feasibility and toxicity of dose-escalated three-dimensional conformal radiotherapy (3D-CRT) concurrent with chemotherapy in patients with primary supratentorial glioblastoma (GBM)...
  30. ncbi request reprint Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomy
    Carlos A Perez
    Department of Radiation Oncology, Mallinckrodt, Institute of Radiology, St Louis, MO 63108, USA
    Clin Prostate Cancer 1:235-41. 2003
    ..Prostate bed irradiation is an effective treatment in a significant proportion of patients who present with a biochemical failure after radical prostatectomy...
  31. pmc Radiation dose-volume effects in radiation-induced rectal injury
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:S123-9. 2010
    ..It is possible that intensity-modulated radiotherapy or proton beam dose distributions require modification of these models because of the inherent differences in low and intermediate dose distributions...
  32. doi request reprint Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era
    Adam S Kibel
    Division of Urology, Department of Surgery, Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri, USA
    J Urol 187:1259-65. 2012
    ..However, it is unknown if survival differences exist among treatments. We analyzed the survival of patients treated with these modalities according to contemporary standards...
  33. ncbi request reprint Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison
    Malika L Siker
    Department of Radiation Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
    J Neurooncol 104:351-6. 2011
    ..1-3.6% of our patients. They have superior survival, even when adjusted for RPA class. More investigations on the unique biologic and clinical characteristics of tumors in this population are needed...
  34. ncbi request reprint Automatic CT simulation optimization for radiation therapy: A general strategy
    Hua Li
    Department of Radiation Oncology, Washington University, St Louis, Missouri 63110
    Med Phys 41:031913. 2014
    ....
  35. pmc Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry
    Jason A Efstathiou
    Massachusetts General Hospital, Department of Radiation Oncology, Boston, MA 02114 2606, USA
    J Oncol Pract 9:e90-5. 2013
    ..The NROR pilot study will provide the framework for expansion to a nationwide electronic registry for radiation oncology. ..
  36. doi request reprint Predicting dose-volume histograms for organs-at-risk in IMRT planning
    Lindsey M Appenzoller
    Department of Radiation Oncology, Washington University, St Louis, MO, USA
    Med Phys 39:7446-61. 2012
    ....
  37. doi request reprint Oligodendrogliomas in children
    Kimberly M Creach
    Department of Radiation Oncology and Mallinckrodt Institute of Radiology, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO 63110, USA
    J Neurooncol 106:377-82. 2012
    ..Our data demonstrate that patients with less than GTR and <3 years at diagnosis are at increased risk for progression and may benefit from more aggressive therapy...
  38. ncbi request reprint Postoperative radiation therapy for grade II and III intracranial ependymoma
    David B Mansur
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 61:387-91. 2005
    ..To retrospectively determine the long-term outcome of intracranial ependymoma patients treated with surgery and postoperative radiation therapy...
  39. ncbi request reprint Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemia
    David B Wilson
    Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Pediatr Hematol Oncol 25:910-3. 2003
    ..By manipulating the GVL effect it is possible to achieve a prolonged bone marrow remission, but only at the expense of unmasking the risk of late extramedullary relapse...
  40. ncbi request reprint A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment
    Reshma Jagsi
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
    Int J Radiat Oncol Biol Phys 84:318-22. 2012
    ..The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care...
  41. ncbi request reprint 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse
    Nobuyuki Oyama
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Boulevard, St Louis, MO 63110, USA
    J Nucl Med 44:549-55. 2003
    ..We also compared the reliability of AC PET in detecting recurrent prostate cancer with that of PET with (18)F-FDG...
  42. ncbi request reprint Radiation therapy in the management of locally advanced prostate cancer
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, Campus Box 8224, 4921 Parkview Place, St Louis, MO 63110, USA
    Curr Urol Rep 7:217-24. 2006
    ....
  43. ncbi request reprint Dose escalation in locally advanced carcinoma of the prostate
    Angel I Blanco
    Department of Radiation Oncology, Washington University, St Louis, MO, USA
    Semin Radiat Oncol 13:87-97. 2003
    ..A confirmatory trial within the Radiation Therapy Oncology Group is underway to determine if dose escalation will improve overall survival in men without compromising quality of life...
  44. ncbi request reprint Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
    Steven J Frank
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Brachytherapy 6:2-8. 2007
    ..This study is aimed at understanding and defining the current patterns of care with respect to prostate brachytherapy for patients with intermediate-risk localized disease in the combined academic and community setting...
  45. ncbi request reprint Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer
    Hua Li
    Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri 63110
    Med Phys 41:031708. 2014
    ..To investigate the impact of exclusively using intravenous (IV) contrast x-ray computed tomography (CT) scans on lung cancer intensity-modulated radiation therapy (IMRT) treatment planning...
  46. ncbi request reprint Method to plan, administer, and verify supine craniospinal irradiation
    Jeff M Michalski
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Appl Clin Med Phys 3:310-6. 2002
    ..The supine patient position does not present any difficulties in field matching or verification...
  47. ncbi request reprint Childhood and adolescent thyroid carcinoma
    Perry W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, Missouri 63110, USA
    Cancer 95:724-9. 2002
    ..This analysis was performed to evaluate the influence of clinical and treatment factors on local tumor control, control of distant metastasis, survival, and complications in children and adolescents with thyroid carcinoma...
  48. ncbi request reprint Event (error and near-miss) reporting and learning system for process improvement in radiation oncology
    Sasa Mutic
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, St Louis, Missouri 63110, USA
    Med Phys 37:5027-36. 2010
    ..The purpose of this work is to report on the design and long-term use of an electronic reporting system in a RT department and compare it to the paper-based reporting system it replaced...
  49. ncbi request reprint Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, Box 8224, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 59:1027-38. 2004
    ....